ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 327 filers reported holding ROYALTY PHARMA PLC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $828,690 | -8.8% | 23,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $908,960 | -1.6% | 23,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $924,000 | -4.4% | 23,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $967,000 | +7.9% | 23,000 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $896,000 | -2.3% | 23,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $917,000 | +10.3% | 23,000 | 0.0% | 0.00% | +100.0% |
| Q3 2021 | $831,000 | -52.9% | 23,000 | -46.5% | 0.00% | -66.7% |
| Q2 2021 | $1,763,000 | -58.1% | 43,000 | -55.4% | 0.00% | -62.5% |
| Q1 2021 | $4,209,000 | -12.9% | 96,500 | 0.0% | 0.01% | -20.0% |
| Q4 2020 | $4,830,000 | +27.6% | 96,500 | +7.2% | 0.01% | +25.0% |
| Q3 2020 | $3,786,000 | +11.4% | 90,000 | +28.6% | 0.01% | 0.0% |
| Q2 2020 | $3,398,000 | – | 70,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |